PER

0.00%

10.5¢ percheron therapeutics limited

For General Information, page-1288

First 1288 Last

Share
Profile

Follow
Vinceanna

265 Posts.

499

04/01/23

21:21

Post #: 65533968
Share

Originally posted by MrLearner: ↑

To ITSA and other posters who are good at due diligence, understand the science and are good at posting technology (ie, not me).

I have just received a copy of a monthly newspaper published in Perth from a relative. The paper is a minor one and it is called "Have-a Go".
The publication of interest to me (and I think for other ANP investors also) is dated December 2022 Volume 32 No.04 Issue No.369.

It contains an article on page 3 about acclaimed Emeritus Professor Byron Kakulus of the Perron Institute in Nedlands WA. It says the now 90 year old Professor Founded the Perron Institute 40 years ago and is a world leader in the field of neuropathology and did pioneering research into DMD.
The Perron Institute and Muscular Dystrophy WA acknowledge they owe their origins to the findings by the Professor. He partnered with a group of parents whose children suffered from Muscular Dystrophy resulting in the formation of Muscular Dystrophy WA.
The article further states that one of the major breakthroughs includes the development of a drug that overcomes the most common gene mutation that causes DMD, revolutionising the treatment of the muscle wasting disease. Young people who would otherwise be in a wheelchair at age 12 are able to walk into their late teens and beyond.

Does anyone know what this drug is? First I have heard of it and the development.

I realise this might be well known to the science people on HC and apologies if this is so.

Unfortunately I dont know how to post the article on HC but I can post it to an email address if needed.

cheers.............Learner

Expand

https://www.medicalresearchdiscoveries.org.au/stories/third-drug-for-duchenne-achieves-us-fda-accelerated-approval/

ANP Price at posting: 10.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 2,250 more messages in this thread...

First 1288 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 10.5¢		Change 0.000(0.00%)		Mkt cap ! $94.66M

Open	High	Low	Value	Volume
10.5¢	10.5¢	9.8¢	$58.09K	574.8K

Buyers (Bids)

No.	Vol.	Price($)
1	38503	10.0¢

Sellers (Offers)

Price($)	Vol.	No.
10.5¢	194063	5

View Market Depth

No.	Vol.	Price($)
1	100000	0.099
2	108491	0.098
1	30927	0.097
1	10004	0.096
3	162157	0.095

Price($)	Vol.	No.
0.105	194063	5
0.110	254663	3
0.115	1334300	6
0.120	381142	9
0.125	110429	2

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PER (ASX) Chart

For General Information, page-1288

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

For General Information, page-1288

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News